Blau Farmaceutica SA
BOVESPA:BLAU3
Blau Farmaceutica SA
BOVESPA:BLAU3
Price:
10.59
BRL
0.38%
Market Closed
Market Cap:
R$2.5B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Blau Farmaceutica SA
BOVESPA:BLAU3
|
BR |
|
C
|
China Northern Rare Earth Group High-Tech Co Ltd
SSE:600111
|
CN |
|
Octaware Technologies Ltd
BSE:540416
|
IN |
|
A
|
Almondz Global Securities Ltd
NSE:ALMONDZ
|
IN |
|
C
|
China Wantian Holdings Ltd
HKEX:1854
|
HK |
|
Silver Mines Ltd
ASX:SVL
|
AU |
|
Writeup Co Ltd
TSE:6580
|
JP |
|
A
|
Asian Granito India Ltd
NSE:ASIANTILES
|
IN |
|
S
|
SAS AB
SWB:SSV2
|
SE |
|
Ceconomy AG
XETRA:CEC
|
DE |
|
Z
|
Zhengwei Group Holdings Co Ltd
HKEX:2147
|
CN |
Multiples-Based Value
The Multiples-Based Value of one
BLAU3
stock under the Base Case scenario is
hidden
BRL.
Compared to the current market price of 10.59 BRL,
Blau Farmaceutica SA
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
BLAU3 Multiples-Based Value
LOCKED
Multiples Across Competitors
BLAU3 Competitors Multiples
Blau Farmaceutica SA Competitors
Blau Farmaceutica SA Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| BR |
|
Blau Farmaceutica SA
BOVESPA:BLAU3
|
2.4B BRL | 1.4 | 8.3 | 5.1 | 6 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
369.2B USD | 6 | 88.2 | 14.6 | 20.3 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
187.5B USD | 5.1 | 24.3 | 14.1 | 14.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
173.4B USD | 5.9 | 20.4 | 12.7 | 15.7 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
111.4B USD | 9.3 | 28.2 | 21.2 | 22.1 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80.5B USD | 5.6 | 17.9 | 13.3 | 15.2 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67B AUD | 3.1 | 34 | 11.3 | 14.2 | |
| NL |
|
argenx SE
XBRU:ARGX
|
39.6B EUR | 11.3 | 36.2 | 39.3 | 40.1 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
